{"public_metrics": {"retweet_count": 2, "reply_count": 1, "like_count": 6, "quote_count": 0}, "in_reply_to_user_id": "807095", "lang": "en", "possibly_sensitive": false, "referenced_tweets": [{"type": "replied_to", "id": "1277626387898216449"}], "entities": {"hashtags": [{"start": 69, "end": 80, "tag": "Remdesivir"}, {"start": 134, "end": 149, "tag": "pharmaceutical"}, {"start": 175, "end": 183, "tag": "COVID19"}], "annotations": [{"start": 29, "end": 35, "probability": 0.9965, "type": "Place", "normalized_text": "America"}], "mentions": [{"start": 0, "end": 8, "username": "nytimes", "id": "807095"}, {"start": 10, "end": 25, "username": "GileadSciences", "id": "309728693"}]}, "source": "Twitter for Android", "text": "@nytimes .@GileadSciences to America, you will have to pay me or not #Remdesivir for you.\nProfiting in a Pandemic should be a crime. \n#pharmaceutical\ncompanies have no shame. #COVID19", "reply_settings": "everyone", "conversation_id": "1277626387898216449", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10040666972", "name": "The New York Times"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "created_at": "2020-06-29T15:43:30.000Z", "id": "1277628771114205184", "author_id": "453825622"}